Recent PTCT News
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 07:14:16 PM
- CHMP Issues Negative Opinion on Translarna™ Following European Commission Request for Review • PR Newswire (US) • 06/28/2024 10:00:00 AM
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 06/21/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/20/2024 11:55:18 AM
- Interim PIVOT-HD Results Demonstrate Evidence of Favorable CNS Biomarker and Clinical Effects at Month 12 in Huntington's Disease Patients • PR Newswire (US) • 06/20/2024 10:30:00 AM
- PTC Therapeutics to Participate at Upcoming Investor Conference • PR Newswire (US) • 05/29/2024 12:00:00 PM
- PTC Therapeutics Announces Validation of Sepiapterin European MAA • PR Newswire (US) • 05/28/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 09:20:10 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/22/2024 02:12:33 PM
- PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation • PR Newswire (US) • 05/20/2024 04:20:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2024 11:20:54 AM
- PTC Therapeutics Announces European Commission Returns Translarna™ Opinion to CHMP For Re-evaluation • PR Newswire (US) • 05/20/2024 11:00:00 AM
- PTC Therapeutics Announces FDA Acceptance and Priority Review of the BLA for Upstaza™ • PR Newswire (US) • 05/14/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/10/2024 09:20:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/08/2024 09:20:12 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2024 07:30:30 PM
- PTC Therapeutics to Participate at Upcoming Investor Conferences • PR Newswire (US) • 05/02/2024 12:00:00 PM
- PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results • PR Newswire (US) • 04/25/2024 08:05:00 PM
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 04/23/2024 08:30:00 PM
- PTC Therapeutics to Host Conference Call to Discuss First Quarter 2024 Financial Results • PR Newswire (US) • 04/11/2024 12:00:00 PM
- PTC Announces Submission of Sepiapterin MAA for Treatment of PKU to EMA • PR Newswire (US) • 03/28/2024 12:30:00 PM
- PTC Therapeutics Provides Key Regulatory Updates • PR Newswire (US) • 03/19/2024 11:30:00 AM
- PTC Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 02/29/2024 09:05:00 PM
- PTC Therapeutics to Participate at Upcoming Investor Conferences • PR Newswire (US) • 02/27/2024 10:20:00 PM
- PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • PR Newswire (US) • 02/22/2024 09:30:00 PM
FEATURED Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM